Integrating Care: The Role of MOUD in Addressing Opioid Use Disorder and Infectious Disease-Presentation

Video Transcription

Video Summary

In the webinar "Integrating Care: The Role of MOUD in Addressing Opioid Use Disorder and Infectious Disease," Dr. Daniel Roza, senior medical director at Acacia Network and ER physician, discusses the critical intersection between opioid use disorder (OUD) and infectious diseases. He emphasizes that individuals with OUD, especially injection drug users, face heightened risks for infections including COVID-19, skin infections, endocarditis, sexually transmitted infections (chlamydia, gonorrhea, syphilis, herpes), HIV, hepatitis B and C, tuberculosis, and complications from adulterants like xylosine. Dr. Roza highlights the importance of integrated, multidisciplinary care combining medications for OUD (MOUD), preventive measures (vaccinations, safe sex, wound care), and timely referrals to address infections effectively. He addresses treatment advances such as long-acting injectable HIV therapies and curative hepatitis C antivirals, while underscoring the need for awareness of unique barriers these populations face. The discussion also stresses the importance of screening, early detection, and treating infections promptly to prevent severe complications. Dr. Roza calls for collaboration across providers in behavioral health, primary care, and emergency settings to improve outcomes for individuals with co-occurring OUD and infectious diseases. The webinar concludes with resources for clinicians to enhance evidence-based care for these vulnerable populations.

Keywords

Opioid Use Disorder

MOUD

Infectious Diseases

Injection Drug Use

HIV

Hepatitis C

Integrated Care

Multidisciplinary Treatment

Screening and Prevention